Search
for
Sort by
Research 301–330 of 1000+
- Experience with sonidegib in patients with advanced basal cell carcinoma: case reports
- Janus Kinase inhibitors in dermatology: a review
- A guide to the use of bioassays in exploration of natural resources
- Ethics Consultation: from Theory to Practice
- Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities
- Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Aplicação da nanotecnologia no tratamento da alopecia
- Ruxolitinib for the treatment of severe alopecia areata
- Cold Plasma An emerging technology for clinical use in wound healing
- Finasteride-Induced Neuropsychiatric Reactions
- Distinct tooth regeneration systems deploy a conserved battery of genes
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- Post-finasteride syndrome – does it really exist?
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
- Hair transplantation for men
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- ПОРІВНЯЛЬНИЙ АНАЛІЗ МЕТОДІВ ВІДНОВЛЕННЯ ВОЛОССЯ В УКРАЇНІ ТА США
- Contact allergy to essential oils cannot always be predicted from allergy to fragrance markers in the baseline series
- Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Design and Validation of a Sensitive Multisteroid LC-MS/MS Assay for the Routine Clinical Use: One-Step Sample Preparation with Phospholipid Removal and Comparison to Immunoassays
- Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti‐inflammatory and antioxidant agents to treat hair loss
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer